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Abstract
Background: Major depression is a severe mental illness that causes heavy social and economic burdens worldwide. A number 
of studies have shown that interaction between individual genetic vulnerability and environmental risk factors, such as stress, 
is crucial in psychiatric pathophysiology. In particular, the experience of stressful events in childhood, such as neglect, abuse, 
or parental loss, was found to increase the risk for development of depression in adult life. Here, to reproduce the gene x 
environment interaction, we employed an animal model that combines genetic vulnerability with early-life stress.
Methods: The Flinders Sensitive Line rats (FSL), a validated genetic animal model of depression, and the Flinders Resistant 
Line (FRL) rats, their controls, were subjected to a standard protocol of maternal separation (MS) from postnatal days 2 
to 14. A basal comparison between the two lines for the outcome of the environmental manipulation was performed at 
postnatal day 73, when the rats were into adulthood. We carried out a global proteomic analysis of purified synaptic terminals 
(synaptosomes), in order to study a subcellular compartment enriched in proteins involved in synaptic function. Two-
dimensional gel electrophoresis (2-DE), mass spectrometry, and bioinformatic analysis were used to analyze proteins and 
related functional networks that were modulated by genetic susceptibility (FSL vs. FRL) or by exposure to early-life stress 
(FRL + MS vs. FRL and FSL + MS vs. FSL).
Results: We found that, at a synaptic level, mainly proteins and molecular pathways related to energy metabolism and 
cellular remodeling were dysregulated.
Conclusions: The present results, in line with previous works, suggest that dysfunction of energy metabolism and cytoskeleton 
dynamics at a synaptic level could be features of stress-related pathologies, in particular major depression.
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Introduction
Major depression (MD) is a severe mental illness that causes 
heavy social and economic burdens worldwide (World Health 
Organization, 2008). It has been estimated that more than 30 mil-
lion people suffer from MD in Europe, with a prevalence of 6.9% 
each year (Wittchen et al., 2011). Stress-related psychiatric disor-
ders such as depression are complex diseases and, although the 
pathophysiology of MD is still essentially unknown, several lines 
of evidence show that the interplay between individual genetic 
vulnerability and environmental risk factors, such as stress, may 
precipitate pathology (Caspi et al., 2002; Caspi and Moffitt, 2006; 
Krishnan and Nestler, 2008). Indeed, stressful adverse events 
in childhood (early-life stress) have been found to increase the 
likelihood of developing the pathology in adult life (Heim and 
Nemeroff, 2001; Caspi et al., 2003; Nugent et al., 2011).
In this study, to reproduce the gene x environment (GxE) 
interaction we employed an animal model that combines 
genetic vulnerability with early-life stress (Wörtwein et  al., 
2006; Husum et al., 2008; Mallei et al., 2008; Musazzi et al., 2010; 
Piubelli et al., 2011; Wegener et al., 2012). Therefore, we subjected 
a genetic animal model of depression, the Flinders Sensitive 
Line (FSL) rats, to a standard protocol of maternal separation 
(MS; Plotsky and Meaney, 1993). Indeed, MS has been shown to 
induce hypothalamic-pituitary-adrenal axis alteration, decrease 
saccharin intake, and increase anxiety-like behavior (Vazquez 
et al., 2000; Gardner et al., 2005; Mallei et al., 2008). The FSL rats, 
a well-validated animal model of depression, were genetically 
selected from Sprague-Dawley rats for their sensitivity to cho-
linergic agents (Overstreet and Russell, 1982). They address the 
validation criteria of construct, face, and predictive validity for 
a good animal model. In fact, the FSL rats display many fea-
tures of depressed individuals, such as reduced general activity, 
decreased appetite and body weight, decreased libido, altera-
tion of REM sleep, anhedonia (after stress), and biochemical 
and behavioral abnormalities (Overstreet et al., 2005; Jiménez-
Vasquez et  al., 2007; Neumann et  al., 2011; Overstreet and 
Wegener, 2013). However, it is worth mentioning that, like other 
selectively-bred animal models of depression, FSL rats exhibit 
some similarities to depressed humans, but cannot reproduce 
all features of human pathology. For instance, FSL rats in non-
stressed conditions do not show anhedonia, a key symptom of 
depression in humans. Therefore, all conclusions of the present 
study must be taken with the caveat that FSL, like other animal 
models, cannot explain all aspects of pathology.
Proteomics allows the simultaneous analysis of hundreds 
of proteins and is a powerful approach to gain insight into the 
molecular mechanisms underlying vulnerability to psychiat-
ric disorders and response to stress (Rohlff and Hollis, 2003; 
Fountoulakis, 2004; Vercauteren et al., 2007; Mallei et al., 2008). 
Thus, proteomic analysis allows us to move beyond the single 
gene/protein/pathway and to explore multiple biological path-
ways and functions related to the pathophysiology of MD.
In this study, we carried out a global proteomics analysis of 
purified synaptic terminals (synaptosomes) from the prefron-
tal and frontal cortices (PFC/FC) and hippocampi (HPC) of FSL 
rats and their controls, the Flinders Resistant Line (FRL) rats, 
in order to study a subcellular compartment enriched in pro-
teins involved in synaptic function. Thus, two-dimensional gel 
electrophoresis (2-DE), mass spectrometry, and bioinformatic 
analysis were used to analyze proteins and related functional 
networks that are modulated by genetic susceptibility (FSL vs. 
FRL) or by exposure to early-life stress (FRL + MS vs. FRL and FSL 
+ MS vs. FSL).
We found that, at a synaptic level, proteins and molecular 
pathways related to energy metabolism and cellular remodeling 
were mainly dysregulated.
Methods
Animals
FSL and FRL from the rat colonies maintained at the 
Karolinska Institutet were housed in standard cages (26 
x 42 x 15 cm) on a 12 h light/dark cycle (lights on at 07:00 
hours) with controlled room temperature (22 ± 1°C) and rela-
tive humidity (45–55%). Food (Lactamin R36) and tap water 
were available ad libitum. Stockholm’s Ethical Committee for 
the Protection of Animals approved the study, and all ani-
mal handling and procedures were conducted in conformity 
with the Karolinska Institutet’s Guidelines for the Care and 
Use of Laboratory Animals, in accordance with the European 
Community Council Directive 86/609/EEC. All efforts were 
made to minimize animal distress and to reduce the num-
bers of animals used in this study.
Maternal Separation
A standard MS procedure was carried out as described before 
(Plotsky and Meaney, 1993; El Khoury et  al., 2006). Briefly, the 
day of delivery was designated as postnatal day (PND) 0. Litters 
from each rat strain were randomly assigned to the MS group 
and were separated from the dam for 180 min/day from PND 2 
to PND 14, beginning at 10:00 hours. Dams were removed from 
the home cages and placed in a new individual cage, then lit-
ters were removed from the nest and placed in clean plastic 
chambers in a incubator at 30–33°C. At the end of the separa-
tion period, first the litters and then the dams were returned to 
the home cages. Control litters were left undisturbed and not 
handled at any time except for during changes of bedding twice 
a week. After weaning at PND 22, rats were housed in groups of 
three to five per cage. Only male rats were used in this study 
(Figure 1).
Purification of Synaptosomes
Synaptosomes were prepared from FSL/FRL rats at the 
Karolinska Institutet, and synaptosome pellets were frozen and 
transferred for processing. Rats (16–20 per experimental group) 
were sacrificed on PND 73, the HPC and the whole frontal lobe 
(PFC/FC) were dissected on ice according to brain atlas coordi-
nates (for PFC/FC plates 4–11; Paxinos and Watson, 1998), and 
synaptosomes were prepared by the Percoll gradient procedure 
according to Dunkley and colleagues (1986), with minor mod-
ifications (Mallei et  al., 2008; Musazzi et  al., 2010), from fresh 
brain tissue. Briefly, HPC or PFC/FC were homogenized in 10 vol 
of homogenization buffer (0.28 M sucrose, 10 mM HEPES pH 7.4, 
0.1 mM EGTA, 20 mM NaF, 5mM Na2PO4, 1mM Na3VO4, and 2 µl/
ml protease inhibitor cocktail [Sigma Aldrich]) using a glass/tef-
lon tissue grinder with clearance of 0.25 mm. The homogenate 
was centrifuged 5 min at 1 000 g, the supernatant was stratified 
on a discontinuous Percoll gradient (6, 10, and 20% v/v in Tris-
buffered sucrose) and centrifuged at 33 500 g for 5 min. The layer 
between 10 and 20% Percoll (synaptosomes) was collected and 
washed by centrifugation, and the resulting pellet was stored 
at -80°C.
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2-DE and Proteome Analysis
2-DE and Imaging
2-DE was carried out as previously described (Mallei et al., 2008 
2011). Synaptosome pellets were dissolved in isoelectric focus-
ing (IEF) buffer (7 M urea, 2 M thiourea, 40 mM Tris, 3 mM tributyl-
phosphine, 2% CHAPS, 1% carrier ampholytes [GE Healthcare], 
and protease inhibitors [Roche Diagnostic]). An aliquot of each 
pellet was dialyzed in 1% sodium dodecyl sulfate in distilled 
water to measure protein concentration by bicinchoninic acid 
assay (Pierce Chemical). Next, 115 µg of synaptosomes were dis-
solved in 125 µl of IEF buffer containing 10 mM iodoacetamide as 
an alkylating agent and a trace of bromophenol blue, and sepa-
rated by IEF in 7 cm pH 3–10 non-linear immobilized pH gradient 
(IPG) strips (Bio-Rad). IEF was performed at 15°C at a maximum 
of 4000 V for a total of 28 000 Vh using Protean IEF Cell (Bio-Rad).
Prior to the second dimension, the IPG strips were equili-
brated in a solution containing 6 M urea, 2% SDS, 375 mM Tris 
pH 8.8, and 4 mM tributylphosphine. After equilibration, the IPG 
strips were placed on top of 8–18% T-gradient polyacrylamide 
gels, and sealed with 0.5% agarose in running buffer. The 2-DE 
gels were then fixed and stained with SYPRO Ruby (Bio-Rad). The 
2-DE gel images were digitally acquired by VersaDoc imaging 
system (Bio-Rad). Image and statistical analysis were carried out 
by PDQuest software (Bio-Rad), to compare replicate groups and 
identify sets of protein spots that show a statistically significant 
difference with a confidence level of 0.05.
Mass Fingerprinting and Protein Identification
Differently expressed spots were cut from gel with a spot cutter 
(Bio-Rad), digested with trypsin, and identified by peptide mass 
fingerprinting at the Proteomics Core Facility of the University of 
Geneva (Scherl et al., 2002). Mascot (Matrix Science Ltd.; Perkins 
et al., 1999) and Profound software (PROWL; http://prowl.rock-
efeller.edu/prowl-cgi/profound.exe) and Aldente tools (http://
au.expasy.org/cgi-bin/aldente/form.cgi) were used to analyze 
spectra. The research was conducted against SWISS-PROT, 
TrEMBL, and NCBInr databases.
Western Blot Analysis
Western blotting was carried out as previously described 
(Musazzi et al., 2010). Briefly, synaptosomal proteins were sepa-
rated on 12% polyacrylamide gels and blotted on polyvinylidene 
fluoride membranes (GE Healthcare). Blocking was performed 
for 1 hour at room temperature in 5% nonfat dry milk in Tris-
buffered saline containing 0.1% Tween 20 (TBST). Membranes 
were then incubated overnight in 5% nonfat dry milk in TBST 
with primary antibodies for aconitate hydratase (1:2000, a gen-
erous gift from Professor Szweda, Oklahoma Medical Research 
Foundation), N-ethylmaleimide sensitive factor (NSF, 1:1000, 
Cell Signalling Technology Inc.), syntaxin-binding protein 1 
(1:3000, BD Biosciences Italy), adenosine triphosphate synthase 
alpha (1:3000, Life Technologies Italia), synaptosomal-associated 
protein 25 (SNAP-25, 1:2000, Synaptic Systems GmbH), dihydro-
pyrimidinase-related protein 2 (DRP-2, 1:2000, Sigma-Aldrich), 
and β-actin (1:10000, Sigma-Aldrich). Following incubation with 
peroxidase-coupled secondary antibodies, protein bands were 
visualized with StoS Protein Detection System (GeneSpin) on 
Hyperfilm ECL films (GE Healthcare). All protein bands used 
were within linear range, and normalized for β-actin levels in 
the same membrane. Quantity One software (Bio-Rad) was used 
for standardization and quantitation.
Bioinformatic Analysis
Functional, canonical pathways and networks analyses were 
generated using Ingenuity Pathways Analysis (IPA, Ingenuity 
Systems, http://www.ingenuity.com). All proteins identified 
by mass spectrometry were considered for the analyses. 
The software identified the biological functions/canonical 
pathways in the Ingenuity Pathways Knowledge Base that 
were most significant to the data set. Fischer’s exact test was 
used to calculate a p-value determining the probability that 
each biological function assigned to that data set is due to 
chance alone. For network generation, a data set contain-
ing protein identifiers and relative fold change values was 
uploaded into the application and mapped to its correspond-
ing gene object in the Ingenuity Pathways Knowledge Base. 
Networks of these focus genes were then algorithmically 
generated based on their connectivity. Fischer’s exact test 
was used to calculate a p-value determining the probability 
that each biological function assigned to that network is due 
to chance alone. The p-value is then expressed as a score (i.e. 
-log10 p-value); a score of 8 or higher is considered extremely 
significant.
Statistical Analysis
In the proteomic study, protein spot intensities were first log 
transformed to fit the normal distribution curve and then ana-
lyzed with student’s t-tests and Partial Least Squares tests using 
PDQuest software. Unpaired two-tailed non-parametric Mann-
Whitney tests were used to analyze Western blotting data using 
GraphPad Prism 4 (GraphPad Software Inc.). In both proteomic 
and Western blotting analyses, significance was assumed at 
p < 0.05.
Results
In this study we employed 2-DE to analyze basal differences in 
synaptosomal protein expression patterns in FSL and FRL rats. 
Moreover, the long-term effect of early-life stress on the syn-
aptosomal protein expression pattern was assessed in both rat 
lines. In addition, IPA was used to identify the biological func-
tions and cellular processes most relevant to the differently-
expressed proteins, and to explore relative pathways/networks 
of the proteins involved.
Figure 1. Schematic representation of the experimental design. Flinders Resistant Line (FRL) and Flinders Sensitive Line (FSL) rats were separated from the dam for 
180 min/day from postnatal day (PND) 2 to PND 14. Control FSL and FRL rats were not separated. All rats were weaned at PND 22. On PND 73 animals were sacrificed 
and prefrontal and frontal cortices (PFC/FC) and hippocampi (HPC) were removed.
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Synaptosomal Proteome Maps
PFC/FC and HPC synaptosomes were prepared from FSL and FRL 
rats, naïve or subjected to MS. Proteins were separated by 2-DE 
gels and only proteomic maps belonging to the same electro-
phoretic run were analyzed in the same match-set in order to 
reduce experimental variability. Examples of rat PFC/FC and HPC 
2-DE maps are reported in Figure 2.
The map containing the largest number of spots was chosen 
as the reference master map and the corresponding spots in all 
gels were matched. The average spot number (± standard devia-
tion [SD]) detected in a gel was 470 ± 53 in PFC/FC, with an aver-
age percentage of matched spots across gels of 87%. In HPC, the 
average number of spots (± SD) detected was 370 ± 15, with an 
average percentage of matched spots across gels of 96.5%.
The following comparisons between experimental groups 
were carried out in both brain areas: FSL vs. FRL, to evaluate 
basal (genetic) differences between rat lines; FRL + MS vs. FRL; 
and FSL + MS vs. FSL to evaluate the effects of GxE interaction.
The number of spots differently modulated in the different 
comparisons are reported in Table 1. Spots with statistically sig-
nificant different levels were excised from gels and identified by 
peptide mass fingerprinting analysis (Table 2 and Table 3).
Prefrontal and Frontal Cortices Synaptoproteomics
Basal Differences Between FSL-FRL in the Prefrontal and Frontal 
Cortices
2-DE proteomic analysis revealed 27 differently-expressed 
protein spots between FSL and FRL rats. Among them, 10 
were successfully identified by mass spectrometry, represent-
ing 11 distinct proteins (one spot containing a mixture of two 
proteins; Table  2). IPA functional analysis tool identified the 
biological functions relevant to the upregulated or downregu-
lated proteins in basal comparison (Figure 3A). The top three 
molecular and cellular functions identified were nucleic acid 
metabolism, small molecule biochemistry, and energy pro-
duction (Table 4). Moreover, IPA was used to explore canoni-
cal pathways statistically relevant in the same comparison. 
The top three canonical pathways were pentose phosphate 
pathway, acetyl-CoA biosynthesis, and sucrose degradation 
(Figure 3B and Table 5).
Effect of Early-Life Stress in FRL Prefrontal and Frontal Cortices 
In FRL rats, MS differently regulated 19 spots and mass spec-
trometry identified 9 spots representing 13 distinct proteins/
protein isoforms (four spots containing a mixture of two pro-
teins; Table 2). The three top molecular and cellular functions 
revealed by IPA analysis were nucleic acid metabolism, small 
molecule biochemistry, and post-translational modification 
(Figure  3C and Table  4). The top three canonical pathways 
were gluconeogenesis, TCA cycle, and glycolysis (Figure 3D and 
Table 5).
Effects of Early-Life Stress in FSL Prefrontal and Frontal Cortices 
MS differently modulated 43 spots in FSL and mass spec-
trometry identified 21 spots representing 24 distinct proteins/
protein isoforms (one spot containing a mixture of four pro-
teins; Table 2). The top three molecular and cellular functions, 
revealed by bioinformatic analysis with IPA, were nucleic acid 
metabolism, small molecule biochemistry, and molecular trans-
port (Figure 3E and Table 4). The top three canonical pathways 
were cell cycle (G2/M DNA damage checkpoint regulation), Myc 
mediated apoptosis signaling, and ERK5 signaling (Figure 3F and 
Table 5).
It is worth mentioning that in the PFC/FC the bioionformatic 
analysis evidenced biological functions and canonical pathways 
mostly related to cellular energy metabolism, including the pen-
tose phosphate pathway, acetyl-CoA biosynthesis, sucrose deg-
radation/glycolysis/gluconeogenesis, and TCA cycle (Table  5). 
Moreover, early-life stress modulated twice the number of spots 
in FSL compared to FRL.
Hippocampus Synaptoproteomics
Basal Differences Between FSL-FRL in Hippocampus
In HPC, 17 protein spots were differently expressed between FSL 
and FRL rats. Among them, 11 were successfully identified by 
mass spectrometry, representing 15 distinct proteins/protein 
isoforms (two spots containing a mixture of three proteins; 
Table  3). The top three biological functions identified by IPA 
were cellular assembly and organization, small molecule bio-
chemistry, and cell morphology (Figure 4A and Table 4). The top 
three pathways were RhoGDI signaling, signaling by Rho fam-
ily GTPases, and remodeling of epithelial adherents junctions 
(Figure 4B and Table 5).
Effect of Early-Life Stress in FRL Hippocampus
 In FRL rats, MS differently regulated 19 spots and mass spec-
trometry identified 16 spots representing 25 distinct proteins/
protein isoforms (five spots containing a mixture of two proteins 
and two spots containing three proteins; Table 3). The three top 
molecular and cellular functions identified by IPA analysis were 
free radical scavenging, small molecule biochemistry, and car-
bohydrate metabolism (Figure  4C and Table  4). The top three 
pathways were superoxide radicals degradation, TCA cycle, and 
mitochondrial dysfunction (Figure 4D and Table 5).
Effects of Early-Life Stress in FSL Hippocampus
 MS differently modulated 19 spots in FSL and mass spectrom-
etry identified 14 spots representing 23 distinct proteins/pro-
tein isoforms (five spots containing a mixture of two proteins, 
and one spot containing a mixture of five proteins; Table 3). The 
top three molecular and cellular functions, revealed by bioin-
formatic analysis with IPA, were protein trafficking, cellular 
assembly and organization, and cellular function and mainte-
nance (Figure 4E and Table 4). The top three canonical pathways 
were cell cycle (G2/M DNA damage checkpoint regulation), Myc-
mediated apoptosis signaling, and ERK5 signaling (Figure 4F and 
Table 5).
The biological functions and canonical pathways most rel-
evant to the differently-expressed proteins in HPC were related 
to cellular remodeling, including cellular assembly and organi-
zation, cellular function and maintenance, cell morphology, and 
Rho GTPase signaling.
Network Analysis
IPA analysis was used to determine networks of proteins signifi-
cantly enriched in the various comparisons. IPA identified four 
networks in PFC/FC and four in HPC. The networks identified are 
shown in Figures 5 and 6, respectively. The proteins involved and 
the network scores and biofunctions associated are shown in 
Tables 6 and 7, respectively.
Western Blot Analysis
To validate our proteomic results, we used Western analysis to 
measure the expression levels of six proteins of interest (NSF, 
ATP synthase alpha, aconitate hydratase, syntaxin-binding 
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protein 1, DRP-2, and SNAP-25; Figures 7 and Table 8). Consistent 
with our 2-DE results, Western analysis confirmed significant 
decreases for NSF (Figure 7A), ATP synthase alpha (Figure 7B), 
and aconitate hydratase (Figure 7C) levels in FSL+MS as com-
pared with FSL+MS in PFC/FC. Western analysis also confirmed 
significantly increased levels of DRP-2 (Figure 7E) in FSL com-
pared to FRL, while SNAP-25 (Figure 7F) showed a trend toward 
increases in FSL+MS compared to FSL+MS in the HPC (Table 8). 
Conversely, Western analysis for syntaxin-binding protein 1 
(Figure  7D) levels in FSL+MS compared to FSL in PFC/FC did 
not confirm the 2-DE results, showing decreased rather than 
increased level.
Discussion
Early-life stress has been recognized as a risk factor for depres-
sion (Heim and Nemeroff, 2001). In the present study we 
employed a standard MS protocol to analyze the impact of early-
life adverse events on the proteomic profile of purified synaptic 
terminals in the FSL/FRL genetic animal model of depression. 
We have previously explored the outcome of the interaction of 
early-life stress with the background of vulnerability of FSL rats. 
We found marked alterations in key regulators of presynaptic 
release/neurotransmission in the basal FSL rats as a result of 
early-life stress, such as blunted responses to the stress of syn-
aptic Erk-MAP kinases. These findings suggested the occurrence 
Figure 2. Representative two-dimensional gel electrophoresis gel images of Sypro-Ruby-stained synaptosomal proteins from (A) prefrontal and frontal cortices or (B) 
hippocampi in FSL rats. Circles and numbers indicate differently-regulated proteins spots (see also Tables 2 and 3).
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Table 1. Comparisons of Experimental Groups
Comparison Spots per gel (mean ± SD) % of matched spots (mean) Modulated spots t-test PLS Common to t-test and PLS
PFC/FC
FSL vs. FRL 497 ± 62 88 27 25 11  9
FRL+MS vs. FRL 436 ± 28 86 19 14  9  4
FSL+MS vs. FSL 504 ± 51 88 43 34 20 11
HPC
FSL vs. FRL 376 ± 14 96 17 15 10  8
FRL+MS vs. FRL 372 ± 6 96 19 17  7  5
FSL+MS vs. FSL 368 ± 21 97 19 14  9  4
The average number of spots per gel with standard deviation (SD) is reported in column 2 for the considered comparison. The average percentage of gel spots 
matched with the standard map for each comparison set is reported in column 3. Two statistical tests were performed: student’s t-test and Partial Least Squares 
analysis (PLS). The total number of spots showing a statistically-significant modulation in student’s t-test (t-test, p < 0.05, column 5) or in PLS analysis (95% sig-
nificance level, column 5) and the number of shared spots between the two tests are indicated (column 6). HPC, hippocampus; MS, maternal separation; PFC/FC, 
prefrontal and frontal cortices.
of synaptic dysfunction in the GxE model. This was accompa-
nied by remodeling of N-methyl-D-aspartate receptor-depend-
ent hippocampal synaptic plasticity (Ryan et al., 2009; Musazzi 
et al., 2010). At the peripheral level (serum), proteomic analysis 
evidenced changes in pathways related with inflammation and 
regulation of metabolism (Carboni et al., 2010).
In the present work, for the first time, we carried out a global 
proteomic analysis of the FSL/FRL model at the synaptic level.
Here we used a bioinformatic approach to analyze the func-
tional relevance of the numerous proteins found dysregulated 
in FSL versus FRL following early-life stress. Interestingly, we 
found a brain region–specific pattern of pathway enrichment. 
Indeed, we found that expression of the proteins involved in 
energy metabolism pathways was mostly changed in the PFC/
FC area, suggesting that in this area energy metabolism is par-
ticularly affected by genetic vulnerability and early-life stress. 
This is not surprising since the brain is a high energy-demand-
ing structure, especially the cortical areas, where glutamatergic 
synapses and neurotransmission are predominant (Bélanger 
et al., 2011). On the contrary, we found that expression of the 
proteins related to cellular remodeling pathways was mainly 
changed in the HPC. Indeed, numerous studies have highlighted 
the notion that changes in brain morphology represent a key 
factor in the response to stress, pathophysiology of depression, 
and antidepressant action. Indeed, volumetric changes in the 
PFC/FC and HPC have been reported both in depressed patients 
and animal models of depression. Furthermore, stress is able to 
induce dendritic retraction and reduction of spine number, thus 
affecting synaptic transmission (McEwen, 2005; Krishnan and 
Nestler, 2008; Gorman and Docherty, 2010; Sanacora et al., 2012; 
Sousa and Almeida, 2012).
Basal Differences Between FSL and FRL in Prefrontal 
and Frontal Cortices
In the present work, we found a number of proteins involved 
in energy metabolism pathways differently expressed in the 
basal comparison of FSL versus FRL in PFC/FC synaptosomes. 
Indeed, we found the energy metabolism proteins isocitrate 
dehydrogenase subunit alpha, fructose bisphosphate aldolase 
C and pyruvate dehydrogenase subunit beta were upregu-
lated in FSL rats versus their control FRL rats. These modifica-
tions are in line with previous clinical and preclinical studies. 
Fructose bisphosphate aldolase C was found to be upregulated 
in the frontal cortices of patients with MD in two proteomic 
studies (Johnston-Wilson et al., 2000; Beasley et al., 2006), while 
pyruvate dehydrogenase (subunit alpha) was found to increase 
in total homogenate of PFC/FC of FSL in a previous proteomic 
study (Piubelli et al., 2011). Moreover, mitochondrial disorders 
(including mutation in the gene coding for pyruvate dehydro-
genase subunit alpha) have been diagnosed in depressed ado-
lescents (Koene et al., 2009).
In addition, we found that several proteins involved in syn-
aptic function were dysregulated as a consequence of genetic 
vulnerability. In basal FSL versus FRL PFC/FC synaptosomes, 
proteins related to synaptic vesicle fusion and recycling were 
downregulated. Indeed, we found lower levels of syntaxin-
binding protein 1 (also known as Munc-18), a protein involved 
in synaptic vesicle exocytosis (Jahn and Fasshauer, 2012); 
dynamin 1, a GTPase involved in clathrin-coated synaptic 
vesicles budding; and heat shock cognate 71 (also known as 
heat shock cognate 70, HSPA8), an ATPase involved in chap-
eroning SNAP-25 during synaptic function and in the clathrin 
uncoating of recycled vesicles (Sharma et al., 2011; McMahon 
and Boucrot, 2011). Interestingly, a recent hypothesis suggested 
that clathrin-dependent membrane and protein traffick-
ing might be core processes involved in the pathophysiology 
of schizophrenia and bipolar disorder (Schubert et  al., 2012). 
Furthermore, a proteomic study that analyzed the postmortem 
dorsolateral PFC from depressed patients, found reduced phos-
phorylation of dynamin-1 at different phosphorylation sites 
(Martins-de-Souza et al., 2012).
Effect of Early-Life Stress in FRL Prefrontal and 
Frontal Cortices
Early-life stress had an important effect on brain metabolic 
pathways in PFC/FC FRL rats. Firstly, we found that the genetic 
vulnerability in FSL and early-life stress in FRL result in a 
similar effect on pyruvate dehydrogenase beta (i.e., increased 
expression), again consistent with the previous proteomic 
study of FSL/FRL (Piubelli et al., 2011). Secondly, we found that 
early-life stress in FRL synaptosomes reduced the expres-
sion of several proteins involved in glycolysis, tricarboxilic 
acid cycle and oxidative phosphorylation (glyceraldehyde-
3-phosphate dehydrogenase, fructose-bisphosphate aldolase 
C, isocitrate dehydrogenase, malate dehydrogenase, NADH-
ubiquinone oxidoreductase 75 kDa), suggesting a reduction 
of energy production. Indeed, a previous proteomic work 
on maternally-separated rats reported a downregulation of 
isocitrate dehydrogenase and glyceraldehyde-3-phosphate 
dehydrogenase similar to what we found here for FRL rats 
Mallei et al. | 7
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Figure 3. Bioinformatic analysis in the prefrontal and frontal cortices. Major biological functions and cellular processes most relevant to the proteins differently 
expressed in: (A) Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (C) FRL after maternal separation (MS), and (E) FSL after MS, as calculated by Ingenuity 
Pathways Analysis software. Canonical pathways most relevant to the proteins differently expressed in: (B) FSL vs. FRL, (D) FRL after MS, and (F) FSL after MS. Biological 
functions and canonical pathways are listed based on higher statistical significance [-log(p value)], with a threshold set at 1.3.
subjected to the same protocol of stress (Marais et al., 2009). 
Interestingly, a previous proteomic study from our group 
showed a similar downregulation of several mitochondrial 
and energy metabolism proteins in PFC/FC synaptosomes fol-
lowing induction of learned helplessness in rats (Mallei et al., 
2011).
12 | International Journal of Neuropsychopharmacology, 2015
Table 4. Molecular and Cellular Functions Identified by IPA in PFC/FC and HPC
Molecular and Cellular Functions p-value Proteinsa
FSL vs. FRL (PFC/FC)
Nucleic Acid Metabolism 2,49E-06 HSPA8, NDUFS1, TKT, ATP6V0D1, IDH3A, PDHB
Small Molecule Biochemistry 2,49E-06 HSPA8, STXBP1, NDUFS1, HNMT, TKT, ATP6V0D1, IDH3A, PDHB, PRDX6
Energy Production 4,91E-05 HSPA8, NDUFS1, ATP6V0D1
Cellular Assembly and Organization 9,52E-05 DNM1, HSPA8, NDUFS1, STXBP1
Cellular Function and Maintenance 9,52E-05 HSPA8, DNM1, NDUFS1, STXBP1
FRL+MS vs. FRL (PFC/FC)
Nucleic Acid Metabolism 1,59E-06 HSPA8, NDUFS1, GNAO1, GAPDH, IDH3A, HSPD1, MDH2, PDHB
Small Molecule Biochemistry 1,59E-06 HSPA8, NDUFS1, GNAO1, GAPDH, IDH3A, HSPD1, MDH2, PDHB, PRDX6
Post-Translational Modification 3,39E-05 HSPA8, HSPD1, PRDX6, ALDOC
Protein Folding 3,39E-05 HSPA8, HSPD1
Cell Death and Survival 1,36E-04 HSPA8, NDUFS1, GNAO1, GAPDH, HSPD1, PRDX6, ALDOC
FSL+MS vs. FSL (PFC/FC)
Nucleic Acid Metabolism 4,53E-06 NSF, ATP5A1, TKT, GNAO1, ATP6V0D1, PKM, CKMT1A/CKMT1B, MDH1, VDAC1
Small Molecule Biochemistry 4,53E-06 STXBP1, YWHAH, TKT, ATP5A1, PKM, ACO2, CKMT1A/CKMT1B, YWHAZ, MDH1, 
PRDX6, NSF, ATP6V0D1, GNAO1, VDAC1
Molecular Transport 7,63E-06 STXBP1, YWHAH, YWHAB, ATP5A1, PKM, YWHAZ, CKMT1A/CKMT1B, MDH1, 
PRDX6, NSF, GNAO1, ATP6V0D1, VDAC1
DNA Replication, Recombination, and Repair 2,81E-04 NSF, ATP5A1, ATP6V0D1, GNAO1, CKMT1A/CKMT1B
Energy Production 2,81E-04 NSF, ATP5A1, ATP6V0D1, PKM, MDH1, VDAC1
FSL vs. FRL (HPC)
Cellular Assembly and Organization 3,84E-05 DPYSL2, NSF, NEFL, ACTB, GNAO1, ACTG1
Small Molecule Biochemistry 8,91E-05 DPYSL2, NSF, SUCLA2, GNAO1, GOT2
Cell Morphology 1,76E-04 DPYSL2, NSF, NEFL, ACTB, GNAO1
Cellular Development 1,76E-04- DPYSL2, NEFL, ACTB, GNAO1
Cellular Function and Maintenance 1,76E-04 DPYSL2, NSF, NEFL, ACTB, GNAO1, ACTG1
FRL+MS vs. FRL (HPC)
Free Radical Scavenging 1,58E-06 SOD2, SOD1, ACTB, ARHGDIA
Small Molecule Biochemistry 9,45E-06 DPYSL2, SOD1, ATP5A1, GLUD1, VIM, SNAP25, ATP6V1E1, HSPA8, SOD2, GOT1, 
IDH3A, IDH3B, ATP6V1B2
Carbohydrate Metabolism 1,57E-05 SOD1, SOD2, GOT1, IDH3A, IDH3B
Amino Acid Metabolism 3,3E-05 DPYSL2, SOD1, GLUD1, GOT1
Nucleic Acid Metabolism 3,42E-05 ATP6V1E1, HSPA8, DPYSL2, SOD2, SOD1, ATP5A1, IDH3A, IDH3B
FSL+MS vs. FSL (HPC)
Protein Trafficking 8,23E-06 YWHAQ, YWHAG, YWHAB, YWHAZ
Cellular Assembly and Organization 5,09E-05 HSPA8, DPYSL2, NDUFS1, YWHAG, CAMK2A, IMMT, YWHAH, NEFL, YWHAZ, INA
Cellular Function and Maintenance 5,09E-05 HSPA8, DPYSL2, NDUFS1, YWHAG, CAMK2A, YWHAH, IMMT, NEFL, INA, HSPD1, 
HSPA2, ATP6V1B2
Molecular Transport 7,05E-05 HSPA8, DPYSL2, NDUFS1, CAMK2A, YWHAH, YWHAB, ATP5A1, YWHAZ, AT-
P6V1B2
Nucleic Acid Metabolism 7,3E-05 PGK1, HSPA8, DPYSL2, NDUFS1, ATP5A1, HSPD1
aProteins are indicated with gene name
FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; IPA, Ingenuity Pathways Analysis; MS, maternal separation; PFC/FC, prefrontal and 
frontal cortices prefrontal cortex.
Effect of Early-Life Stress in FSL Prefrontal and 
Frontal Cortices
Early MS had a deeper impact on the synaptic proteome of FSL 
compared with FRL rats, with twice the number of proteins found 
dysregulated. In FSL, we found a decrease in proteins related to 
energy metabolism, such as components of oxidative phospho-
rylation complexes I  (NADH-ubiquinone oxidoreductases), III 
(cytochrome C1), and V (ATP synthase alpha), malate dehydro-
genase, and aconitate hydratase. Notably, neuroimaging studies 
have shown reduced levels of ATP in the brains of patients with 
mood disorders compared to controls, thus indicating lower met-
abolic brain activity in depressed patients (Moretti et al., 2003). 
Indeed, we found reduced levels of ATP synthase alpha in FSL 
rats subjected to MS. On the contrary, we found increased levels 
of creatine kinase, the enzyme that catalyzes the conversion of 
creatine to its high energy phosphorylated form phosphocreatine 
with use of ATP (Béard and Braissant, 2010). This upregulation of 
creatine kinase in response to early-life stress could be explained 
by a compensatory mechanism for the possible reduction of ATP, 
due to lower ATP synthase alpha level.
Early-life stress also reduced expression of two proteins 
involved in synaptic transmission: NSF, an ATPase involved in 
the disassembly of SNARE complexes and synaptic vesicle recy-
cling (Südhof and Rizo, 2011) and clathrin light chain B.  This 
piece of evidence further supports the involvement of clathrin-
mediated endocythosis/trafficking in the pathophysiology of 
psychiatric diseases (Schubert et al., 2012).
Basal Differences Between FSL and FRL in 
Hippocampus
In the present study we report modifications in the expression of 
several proteins involved in cellular remodeling processes; it is 
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interesting to note that these modifications were found mainly 
in HPC. Actin is a key cytoskeletal protein involved in axon guid-
ance, synapse development, and synaptic plasticity (Yao et al., 
2006; Wong et al., 2013; Chia et al., 2013). Here we found a dys-
regulation of several actin isoforms in basal FSL versus FRL rats. 
This result is in agreement with a previous proteomic work in 
the same GxE animal model, that analyzed the total homoge-
nate of PFC/FC and HPC (Piubelli et al., 2011). Moreover, in the 
present study, neurofilament light neuropeptide (NEFL), an 
intermediate neurofilament protein involved in axonal and den-
dritic growth (Yuan et al., 2006), was found to be modulated by 
genetic vulnerability (FSL vs. FRL).
Effect of Early-Life Stress in FRL Hippocampus
In FRL, early-life stress modulated levels of actin isoforms in 
HPC synaptosomes; similar modifications have been found 
previously in the HPC total homogenate of FRL rats subjected 
to the same protocol of MS (Piubelli et  al., 2011). In addition, 
we found a downregulation of DRP-2 in both FRL and FSL 
(see below). Notably, we found an increased expression of the 
SNARE-complex protein SNAP-25 and downregulation of three 
distinct protein isoforms of HSPA8, a component of the chap-
erone complex that prevents misfolding of SNAP-25 (Sharma 
et al., 2011; Südhof, 2013).
Effect of Early-Life Stress in FSL Hippocampus
NEFL and alpha-internexin, other intermediate neurofilament 
proteins involved in axonal and dendritic growth (Yuan et  al., 
2006), were found to be modulated by early-life stress in FSL HPC. 
In line with the present findings, modifications of these two pro-
teins were also found in other animal models of depression, such 
as the psychosocial stress (Carboni, Piubelli, et al., 2006) and the 
learned helplessness model (Reinés et  al., 2004), or after long-
term treatment with the stress hormone corticosterone (Zhao 
et  al., 2009). Notably, enriched environment, physical exercise, 
chronic electroconvulsive shock, or treatment with valproic acid 
(but not fluoxetine) modulate NEFL levels in rodents (Vaidya et al., 
2000; Ding et al., 2006; Ferrero et al., 2007; Sifonios et al., 2009).
In the present study, we found additional evidence involving 
cytoskeleton-remodeling pathways as an outcome of early-life 
Table 5.  Canonical Pathways identified by IPA in PFC/FC and HPC.
Ingenuity Canonical pathways p-value Proteinsa
FSL vs. FRL (PFC/FC)
Pentose Phosphate Pathway (Non-oxidative Branch) 4,25E-03 TKT
Acetyl-CoA Biosynthesis I (Pyruvate Dehydrogenase Complex) 4,25E-03 PDHB
Sucrose Degradation V (Mammalian) 5,66E-03 ALDOC
Pentose Phosphate Pathway 7,07E-03 TKT
Glutathione Redox Reactions I 1,12E-02 PRDX6
FRL+MS vs. FRL (PFC/FC)
Gluconeogenesis I 4,4E-07 GAPDH, MDH2, ALDOC
TCA Cycle II (Eukaryotic) 9,39E-05 IDH3A, MDH2
Glycolysis I 1,2E-04 GAPDH, ALDOC
NADH Repair 1,93E-03 GAPDH
Synaptic Long Term Depression 3,42E-03 GNAO1, PRDX6
FSL+MS vs. FSL (PFC/FC)
Cell Cycle: G2/M DNA Damage Checkpoint Regulation 2,95E-07 YWHAG, YWHAH, YWHAB, YWHAZ
Myc Mediated Apoptosis Signaling 1E-06 YWHAG, YWHAH, YWHAB, YWHAZ
ERK5 Signaling 1,4E-06 YWHAG, YWHAH, YWHAB, YWHAZ
IGF-1 Signaling 7,91E-06 YWHAG, YWHAH, YWHAB, YWHAZ
14-3-3-mediated Signaling 1,66E-05 YWHAG, YWHAH, YWHAB, YWHAZ
FSL vs. FRL (HPC)
RhoGDI Signaling 1,07E-04 ACTB, GNAO1, ACTG1
Signaling by Rho Family GTPases 2,49E-04 ACTB, GNAO1, ACTG1
Remodeling of Epithelial Adherent Junctions 7,08E-04 ACTB, ACTG1
FAK Signaling 1,12E-3 ACTB, ACTG1
VEGF Signaling 1,25E-3 ACTB, ACTG1
FRL+MS vs. FRL (HPC)
Superoxide Radicals Degradation 2,36E-05 SOD1, SOD2
TCA Cycle II (Eukaryotic) 3,93E-04 IDH3A, IDH3B
Mitochondrial Dysfunction 6,73E-04 SOD2, NDUFV2, ATP5A1
NRF2-mediated Oxidative Stress Response 1,51E-03 SOD1, SOD2, ACTB
Glutamate Biosynthesis II 2,58E-03 GLUD1
FSL+MS vs. FSL (HPC)
Cell Cycle: G2/M DNA Damage Checkpoint Regulation 1,45E-09 YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
Myc Mediated Apoptosis Signaling 6,83E-09 YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
ERK5 Signaling 1,04E-08 YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
IGF-1 Signaling 9,32E-08 YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
14-3-3-mediated Signaling 2,39E-07 YWHAQ, YWHAG, YWHAH, YWHAB, YWHAZ
aProteins are indicated with gene name
FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; IPA, Ingenuity Pathways Analysis; MS, maternal separation; PFC/FC, prefrontal and 
frontal cortices.
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stress. The 14-3-3 proteins are adaptor proteins involved in 
intracellular signaling, cell growth, apoptosis, ion channel func-
tion, and neurotransmission (Berg et al., 2003). Moreover, 14-3-3 
proteins interact with NEFL and have a role in NEFL disassembly 
(Miao et al., 2013). The increased levels of 14-3-3 proteins, found 
here in both PFC/FC and HPC synaptosomes following MS in FSL 
rats, suggest increased disassembly of neurofilaments and pos-
sibly altered dynamics of neurofilaments at the synaptic level. 
Increased levels of 14-3-3 have also been found in the chronic 
unpredictable stress model of depression (Mu et  al., 2007). 
Interestingly, 14-3-3 proteins have been found to be altered in 
schizophrenia and bipolar disorder (Altar et al., 2009) after treat-
ment with the antidepressant fluoxetine, or the mood stabilizers 
valproate and lithium (Altar et al., 2009; Nanavati et al., 2011).
DRP-2 (also known as CRMP2) is a cytosolic protein 
involved in axonal guidance and growth, cell migration, signal 
Figure 4. Bioinformatic analysis in the hippocampus. Major biological functions and cellular processes most relevant to the proteins differently expressed in: (A) 
Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (C) FRL after maternal separation (MS), and (E) FSL after MS, as calculated by Ingenuity Pathways Analysis 
software. Canonical pathways most relevant to the proteins differently expressed in: (B) FSL vs. FRL, (D) FRL after MS, and (F) FSL after MS. Biological functions and 
canonical pathways are listed based on higher statistical significance [-log(p value)], with a threshold set at 1.3.
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transduction, and neuronal differentiation (Charrier et al., 2003; 
Mallei et  al., 2011; Ip et  al., 2014). DRP-2 interacts with the 
cytoskeleton proteins tubulin, actin, and vimentin, and is able 
to regulate microtubule dynamics, based on its phosphorylated 
state, by stabilizing/destabilizing tubulin heterodimer (Khanna 
et  al., 2012). We found DRP-2 downregulated following MS in 
both FRL and FSL rats. Two proteomic studies of post-mortem 
brain of depressed patients found DRP-2 downregulated as 
in the present study (Johnston-Wilson et  al., 2000; Martins-
de-Souza et  al., 2012), while a third found DRP-2 upregulated 
(Beasley et al., 2006). Involvement of DRP-2 in the pathophysiol-
ogy of depression is confirmed also by several preclinical stud-
ies (Khawaja et  al., 2004; Carboni, Vighini, et  al., 2006; Mallei 
et al., 2011).
In the present work, as already mentioned, the changes in 
proteins involved in energy metabolism were found mainly in 
PFC/FC; however, in HPC we also found a reduction of ATP syn-
thase alpha following early-life stress in FSL, similar to what we 
observed in PFC/FC.
Network Analysis
In genetically complex diseases such as depression, multi-
ple genetic factors of small effect interact among themselves 
and with environmental factors to precipitate the pathology 
(Wong and Licinio, 2001). In this context it is important not only 
to identify the many genes and proteins involved but also to 
unveil the molecular pathways associated. It is interesting to 
note that in the networks related to basal comparison in both 
PFC/FC (Figure 5A) and HPC (Figure 6A), a major hub is formed 
by ubiquitin C (Ubc). Ubc, in combination with the 26S protea-
some, has a central role in proteolytic degradation of substrates 
Figure 5. Significant pathway networks based on the proteins differently expressed between (A) Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (B) FRL 
after maternal separation (MS), and (C and D) FSL after MS, in prefrontal and frontal cortices. Protein nodes with a colored background correspond to the identified 
proteins in the various comparisons, while other proteins were added from the Ingenuity database. The intensity of node colors indicates the degree of upregulation 
(red) or downregulation (green). Fischer’s exact test was used to calculate a p-value determining the probability that each biological function assigned to that network 
is due to chance alone.
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in multiple processes but is involved also in non-proteolytic 
regulatory mechanisms, including membrane protein endocy-
tosis and intracellular trafficking (Hochstrasser, 2009). Moreover, 
the ubiquitin-proteasome pathway has been also involved in 
synaptic plasticity (Hegde, 2010). In the basal PFC/FC network 
(Figure  5A), Ubc is connected to a cluster formed by proteins 
involved in synaptic function, such as dynamin 1, syntaxin-
binding protein 1, and synaptosomal associated protein of 
25 kDa. Moreover, Ubc is also linked through multiple connec-
tions to a cluster of proteins that form the pyruvate dehydro-
genase complex, a key mitochondrial enzyme that links the 
glycolysis to the tricarboxylic acid cycle (Patel and Korotchkina, 
2006). Instead, in the network related to the basal comparison in 
HPC (Figure 6A), Ubc is connected to a large cluster of proteins 
that interact with the cytoskeletal protein actin. Therefore, net-
work analysis of the present results shows cross-interaction of 
pathways for energy metabolism, cytoskeleton remodeling, and 
synaptic transmission.
Validation by Western Blot Analysis
Validation of dysregulated proteins by independent methods is 
an important step of a proteomic study. In this work, we used 
Western analysis to confirm the differential expression of six 
proteins found dysregulated in the present study. These proteins 
were selected based on expression levels observed in 2-DE maps, 
Figure 6.  Significant pathway networks based on the differently expressed protein between (A) Flinders Sensitive Line (FSL) vs. Flinders Resistant Line (FRL), (B and 
C) FRL after maternal separation (MS), and (D) FSL after MS, in the hippocampus. Protein nodes with a colored background correspond to the identified proteins in 
the various comparisons, while other proteins were added from the Ingenuity database. The intensity of node colors indicates the degree of upregulation (red) or 
downregulation (green). Fischer’s exact test was used to calculate a p-value determining the probability that each biological function assigned to that network is due 
to chance alone.
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Table 7. Networks of Proteins identified by IPA in HPC.
Proteins in the networka Scoreb No. of focus proteins High-level functions
FSL vs. FRL
ACTB, ACTG1, Actin, CAP2, CFL2, COTL1, CPNE2, Dmd, DPYSL2, 
EPS8L1, EPS8L2, GAS8, GNAO1, GOT2, GPR158, HIP1R, KCNQ2, 
KLHL17, MAF1, NCALD, NDUFS3, NEFL, NSF, PCYT1B, PHACTR1, 
PLS1, RAB8B, RGS17, SPTBN2, SSH1, SUCLA2, SULT2B1, TRPM7, 
UBC, XPO6
26 9 Cellular Assembly and Organization, 
Cancer, Connective Tissue 
Disorders
FRL+MS vs. FRL
26s Proteasome, ACTB, Actin, Akt, ATP5A1, Beta Tubulin, BLK, BMP, 
DNAJC6, DPYSL2, ENO2, FSH, GLUD1, GOT1, Hsp70, Hsp90, HSP, 
HSPA2, HSPA8, Insulin, MT3, NFkB (complex), NMDA Receptor, 
NTF3, p85 (pik3r), PACRG, RTN4R, SEMA3A, SNAP25, SOD1, SOD2, 
Sod, Spectrin, Tubulin, VIM
30 12 Free Radical Scavenging, Cell 
Morphology, Cellular Assembly 
and Organization
AP2A1, ARHGDIA, ASPSCR1, ATP6V1A, ATP6V1B1, ATP6V1B2, 
ATP6V1E1, ATP6V1G2, AXIN1, CRMP1, DBI, GDI1, GLMN, IDH3A, 
IDH3B, IDH3G, IPO9, MECP2, MYC, NDUFS7, NDUFV2, NGLY1, 
NSFL1C, PHAX, Phb, ROCK2, RPL22, RTN4, SRP14, TUBA1A, UBC, 
UBXN6, UBXN2A, UBXN2B, VAV1
18 8 Carbohydrate Metabolism, Nucleic 
Acid Metabolism, Small Molecule 
Biochemistry
FSL+MS vs. FSL
14-3-3, 14-3-3 (β,γ,θ,η,ζ), 14-3-3 (η,θ,ζ), 26s Proteasome, Actin, Akt, 
ATP5A1, Calmodulin, CAMK2A, CaMKII, CD3, DPYSL2, ERK, 
Histone h3, HSP, HSPA2, HSPA8, HSPD1, IMMT, INA, ITPKA, 
NDUFS1, NEFL, p85 (pik3r), PGK1, PI3K (complex), REM1, REM2, 
TCR, TUFM, YWHAB, YWHAG, YWHAH, YWHAQ, YWHAZ
48 17 Protein Trafficking, Cellular 
Assembly and Organization, 
Cellular Function and 
Maintenance
aProteins are indicated with gene name
bScores >3 were considered significant (p<0.001)
FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; HPC, hippocampus; IPA, Ingenuity Pathways Analysis; MS, maternal separation.
Table 6. Networks of Proteins Identified by IPA in PFC/FC.
Proteins in the networka Scoreb No. of focus proteins High-level functions
FSL vs. FRL
ALDOC, ATP6V0D1, DLAT, DLD, DNAJA4, DNAJB12, DNM1, 
FBXO11, FBXO45, FH, HNMT, HSPA8, HTT, IDH3A, INSR, 
MAPK3, NDUFS1, PDHB, PDHX, PRDX6, PRNP, SNAP25, Snare, 
SNPH, STX2, STX3, STXBP1, STXBP5, SYN3, SYTL3, TGFB1, 
TKT, TMEM132A, UBC, ZFAND2A
32 11 Cellular Function and Maintenance, 
Molecular Transport, Lipid Metabolism
FRL+MS vs. FRL
Akt, ALDOC, ASB9, CD3, DNAJB12, DNAJC6, DNAJC13, ETFB, 
FAM103A1, FBXO45, GAPDH, GNAO1, GPR158, HIF1A, HSPA8, 
HSPD1, IDH3A, IDH3B, IDH3G, IKBKG, MDH2, MPST, MYC, 
NCALD, NDUFS1, NGB, p85 (pik3r), PDHB, Pgk, PRDX6, RGS17, 
TMEM132A, TST, UBC, ZFAND2A
28 10 Nucleic Acid Metabolism, Small 
Molecule Biochemistry, Carbohydrate 
Metabolism
FSL+MS vs. FSL
14-3-3, 14-3-3 (β,ε,ζ), 14-3-3 (β,γ,θ,η,ζ), 14-3-3 (η,θ,ζ), AANAT, Akt, 
ARRB2, ATP5A1, CBY1, CKMT1A/CKMT1B, CLTB, DENND4A, 
FAM13B, FAM53C, HECTD4, Histone h3, KIAA0101, LRFN1, 
MLXIP, Phb, PKM, PRDX6, RALGPS2, REM1, REM2, SAMD4A, 
SAMD4B, SH3BP5L, SYNPO2, TKT, TNF, YWHAB, YWHAG, 
YWHAH, YWHAZ
26 11 Cell Morphology, Embryonic 
Development, Organ Development
ACO2, ATP6V0D1, CSNK1G3, CYC1, GNAO1, GPR158, MDH1, 
NAPG, ND2, ND3, ND4L, NDUFA6, NDUFA8, NDUFA9, 
NDUFAF1, NDUFAF3, NDUFAF4, NDUFB6, NDUFS3, NDUFS5, 
NDUFS6, NDUFS7, NDUFS8, NDUFV2, NGB, NOA1, NSF, 
PANK2, RGS17, SLC25A24, STXBP1, SYTL3, UBC, UQCR10, 
VDAC1
23 10 Hereditary Disorder, Metabolic Disease, 
Cardiovascular Disease
aProteins are indicated with gene name
bScores >3 were considered significant (p<0.001)
FSL, Flinders Sensitive Line; FRL, Flinders Resistant Line; IPA, Ingenuity Pathways Analysis; MS, maternal separation; PFC/FC, prefrontal and frontal cortices.
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Figure 7.  Validation of two-dimensional gel electrophoresis results. (A) N-ethylmaleimide sensitive factor (NSF), (B) ATP synthase α, (C) aconitate hydratase, and (D) 
Syntaxin-binding protein 1 protein levels were analyzed in prefrontal and frontal cortices synaptosomes of Flinders Sensitive Line (FSL) and Flinders Resistant Line (FRL) 
after maternal separation (MS) by Western blot. Protein levels were normalized to β-actin and expressed as % relative to FSL rats. Data are presented as mean ± standard 
error of the mean (SEM; n = 6–8). Mann-Whitney test, *p < 0.01; **p < 0.001. (E) Dihydropyrimidinase-related protein 2 (DRP-2) protein levels were analyzed in hippocampus 
(HPC) synaptosomes of FRL and FSL by Western blot. Protein levels were normalized to β-actin and expressed as % relative to FRL rats. Data are presented as mean ± SEM 
(n = 9–12). Mann-Whitney test, **p < 0.001. (F) Synaptosomal-associated protein 25 (SNAP-25) protein levels were analyzed in HPC synaptosomes of FRL and FRL after MS 
by Western blot. Protein levels were normalized to β-actin and expressed as % relative to FRL rats. Data are presented as mean ± SEM (n = 10–11). Mann-Whitney test.
fold-changes, and availability of commercial antibodies. The six 
proteins were NSF, ATP synthase alpha, aconitate hydratase, syn-
taxin-binding protein 1, DRP-2, and SNAP-25. Our results show 
a strong agreement with the 2-DE expression changes, with the 
exception of syntaxin-binding protein 1, which showed change 
in the opposite direction (decrease). This discrepancy could be 
explained by the fact that 2-DE is able to detect the differential 
expression of single isoforms or post-translational modifica-
tions of a protein, while Western analysis can measure only the 
total amount of that protein. Indeed, syntaxin-binding protein 1 
has two alternatively-spliced isoforms and several phosphoryla-
tion sites (Latham and Meunier, 2007). It is possible that 2-DE 
experiment highlighted a change in protein expression of a low-
abundant post-translational modified isoform. Furthermore, 
in a previous work we found a similar reduction of syntaxin-
binding protein 1 in HPC synaptosomes from FSL subjected to 
MS by using Western blotting analysis (Musazzi et al., 2010). The 
case for syntaxin-binding protein 1 in this study highlights the 
importance of protein post-translational modifications. This is 
exemplified by the finding that some proteins appear on gels 
in multiple spots. For instance, HSPA8 protein appears on the 
gel in Figure 2B in at least 4 spots (1903, 1907, 2901, 2902) with 
same molecular weight, and 1 spot (1905) with higher molecular 
weight. The first 4 spots are likely to be different post-transla-
tional modifications of the same protein. Therefore, changes in 
post-translational modifications can be at least as important as 
expression changes in regulating protein function, and in turn 
the phenotype of FSL.
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Table 8. Proteins Selected for Western Blotting Validations.
Proteins Fold change WB p-value WBa Fold change 2-DE spots
FSL+MS vs. FSL (PFC/FC)
NSF -1.23 p = 0,0019 -1.2
ATP synthase subunit alpha(b) -1.25 p = 0,0080 -2.3; -1.8
Aconitate hydratase -1.31 p = 0,0002 -1.3
Syntaxin-binding protein 1 -1.25 p = 0,0047 1.9
FSL vs. FRL (HPC)
DRP-2 1.45 p = 0,0003 1.8
FRL+MS vs. FRL (HPC)
SNAP-25 1.12 p = 0,0726 1.3
aUnpaired two-tailed Mann-Whitney test p-value
bMultiple spots of this protein were dysreguated in 2-DE
2-DE, two-dimensional gel electrophoresis; ATP, adenosine triphosphate; DRP-2, dihydropyrimidinase-related protein 2; FSL, Flinders Sensitive Line; FRL, Flinders 
Resistant Line; HPC, hippocampus; MS, maternal separation; NSF, N-ethylmaleimide sensitive factor; PFC/FC, prefrontal and frontal cortices; SNAP-25, synaptosomal-
associated protein 25; WB, Western blot analysis.
Conclusion
Taken together, our results indicate an overall dysregulation 
of proteins related to energy metabolism in PFC/FC of FSL/FRL 
as a consequence of genetic vulnerability and early-life stress. 
Indeed, mitochondrial dysfunction and mitochondrial regula-
tion of energy metabolism could be central in the pathophysi-
ology of stress-related pathologies such as depression (Morava 
and Kozicz, 2013; Picard et al., 2014). In addition, the dysregu-
lation of structural proteins found here in HPC suggests that 
genetic vulnerability and early-life stress may cause perturba-
tion of cytoskeleton dynamics at the synaptic level, which is 
now being recognized as a cellular/molecular feature of depres-
sion (Nakatani et al., 2007; Wong et al., 2013).
Interestingly, it was recently found that the depressed-like 
phenotype of FSL rats could be linked to hyperfunctioning of a 
G protein–coupled, inward rectifying potassium channel (GIRK). 
Indeed, GIRK knockout mice showed reduced hypothermic 
responses to virtually all drugs that typically induce greater 
hypothermic response in FSL rats. Possible hyperfunctioning of 
GIRK could explain the increased sensitivity to multiple G pro-
tein–coupled receptors in FSL (Overstreet and Wegener, 2013). 
We wonder whether the marked proteomic changes we found 
in FSL could be linked in some way to GIRK abnormalities in 
this rat line. Additional experiments are required to explore this 
interesting hypothesis.
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